Viewing Study NCT00003658


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2026-02-20 @ 3:41 PM
Study NCT ID: NCT00003658
Status: COMPLETED
Last Update Posted: 2013-06-25
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module